Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Y Kim

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Hepatology (Baltimore, Md.)|May 17, 2020
Liver Biochemistries in Hospitalized Patients With COVID-19Patricia P Bloom, Eric A Meyerowitz, Zoe Reinus, et al.
Digestive Diseases and Sciences|September 10, 2017
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentJustin Chan, Neliswa Gogela, Hui Zheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteriaBarbara H McGovern, Christopher E Birch, Melinda J Bowen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Outcomes and treatment of acute hepatitis C virus infection in a United States populationKathleen E Corey, Andrew S Ross, Alysse Wurcel, et al.
The Journal of Infectious Diseases|August 14, 2009
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infectionBarbara H McGovern, Ellen H Nagami, Christopher E Birch, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 22, 2023
Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failureWonkyung J Cho, Destiny Harden, Daiana Moreno, et al.
Frontiers in Medicine|March 13, 2023
Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trialMyung-Ho Kim, Josh Elbaz, Nikolaus Jilg, et al.
The Lancet. HIV|July 11, 2022
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis BAmir M Mohareb, Joseph Larmarange, Arthur Y Kim, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|July 21, 2018
The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost AnalysisAlysse G Wurcel, Deirdre J Burke, Jianing J Wang, et al.
Plos One|April 30, 2015
Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort studyMeghan E Sise, Elke S Backman, Julia B Wenger, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|May 17, 2020
Liver Biochemistries in Hospitalized Patients With COVID-19Patricia P Bloom, Eric A Meyerowitz, Zoe Reinus, et al.
Digestive Diseases and Sciences|September 10, 2017
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatmentJustin Chan, Neliswa Gogela, Hui Zheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteriaBarbara H McGovern, Christopher E Birch, Melinda J Bowen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Outcomes and treatment of acute hepatitis C virus infection in a United States populationKathleen E Corey, Andrew S Ross, Alysse Wurcel, et al.
The Journal of Infectious Diseases|August 14, 2009
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infectionBarbara H McGovern, Ellen H Nagami, Christopher E Birch, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 22, 2023
Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failureWonkyung J Cho, Destiny Harden, Daiana Moreno, et al.
Frontiers in Medicine|March 13, 2023
Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trialMyung-Ho Kim, Josh Elbaz, Nikolaus Jilg, et al.
The Lancet. HIV|July 11, 2022
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis BAmir M Mohareb, Joseph Larmarange, Arthur Y Kim, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|July 21, 2018
The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost AnalysisAlysse G Wurcel, Deirdre J Burke, Jianing J Wang, et al.
Plos One|April 30, 2015
Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort studyMeghan E Sise, Elke S Backman, Julia B Wenger, et al.
Pageof 20